Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Parikh V, Kutlu MG, Gould TJ.

Schizophr Res. 2016 Mar;171(1-3):1-15. doi: 10.1016/j.schres.2016.01.020. Review.

PMID:
26803692
3.

Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Greenwood TA, Swerdlow NR, Gur RE, Cadenhead KS, Calkins ME, Dobie DJ, Freedman R, Green MF, Gur RC, Lazzeroni LC, Nuechterlein KH, Olincy A, Radant AD, Ray A, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Tsuang DW, Tsuang MT, Turetsky BI, Light GA, Braff DL.

Am J Psychiatry. 2013 May;170(5):521-32. doi: 10.1176/appi.ajp.2012.12020186.

4.

Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Olincy A, Freedman R.

Handb Exp Pharmacol. 2012;(213):211-32. doi: 10.1007/978-3-642-25758-2_8. Review.

5.

Association between the 2-bp deletion polymorphism in the duplicated version of the alpha7 nicotinic receptor gene and P50 sensory gating.

Flomen RH, Shaikh M, Walshe M, Schulze K, Hall MH, Picchioni M, Rijsdijk F, Toulopoulou T, Kravariti E, Murray RM, Asherson P, Makoff AJ, Bramon E.

Eur J Hum Genet. 2013 Jan;21(1):76-81. doi: 10.1038/ejhg.2012.81.

6.

Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia.

Stephens SH, Franks A, Berger R, Palionyte M, Fingerlin TE, Wagner B, Logel J, Olincy A, Ross RG, Freedman R, Leonard S.

Psychiatr Genet. 2012 Feb;22(1):1-14. doi: 10.1097/YPG.0b013e32834c0c33.

7.

Copy number variants: a new molecular frontier in clinical psychiatry.

Moreno-De-Luca D, Cubells JF.

Curr Psychiatry Rep. 2011 Apr;13(2):129-37. doi: 10.1007/s11920-011-0183-5.

8.
9.

The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype.

Sinkus ML, Wamboldt MZ, Barton A, Fingerlin TE, Laudenslager ML, Leonard S.

Physiol Behav. 2011 Aug 3;104(2):321-6. doi: 10.1016/j.physbeh.2010.11.007.

10.

Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, Freedman R, Adams CE.

J Child Psychol Psychiatry. 2010 May;51(5):535-49. doi: 10.1111/j.1469-7610.2009.02187.x. Review.

11.

Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.

Mexal S, Berger R, Logel J, Ross RG, Freedman R, Leonard S.

J Mol Neurosci. 2010 Jan;40(1-2):185-95. doi: 10.1007/s12031-009-9233-4. Erratum in: J Mol Neurosci. 2010 Jan;40(1-2):267.

12.

A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.

Sinkus ML, Lee MJ, Gault J, Logel J, Short M, Freedman R, Christian SL, Lyon J, Leonard S.

Brain Res. 2009 Sep 29;1291:1-11. doi: 10.1016/j.brainres.2009.07.041.

13.

The genetics of bipolar disorder.

Barnett JH, Smoller JW.

Neuroscience. 2009 Nov 24;164(1):331-43. doi: 10.1016/j.neuroscience.2009.03.080. Review.

14.

Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia.

Stephens SH, Logel J, Barton A, Franks A, Schultz J, Short M, Dickenson J, James B, Fingerlin TE, Wagner B, Hodgkinson C, Graw S, Ross RG, Freedman R, Leonard S.

Schizophr Res. 2009 Apr;109(1-3):102-12. doi: 10.1016/j.schres.2008.12.017.

15.

Smoking, Genetics and Schizophrenia: Evidence for Self Medication.

Leonard S, Mexal S, Freedman R.

J Dual Diagn. 2007 Nov 1;3(3-4):43-59.

16.

Genome-wide linkage analyses of quantitative and categorical autism subphenotypes.

Liu XQ, Paterson AD, Szatmari P; Autism Genome Project Consortium..

Biol Psychiatry. 2008 Oct 1;64(7):561-70. doi: 10.1016/j.biopsych.2008.05.023.

17.

Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Olincy A, Stevens KE.

Biochem Pharmacol. 2007 Oct 15;74(8):1192-201. Review.

19.

Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder.

Braff DL, Freedman R, Schork NJ, Gottesman II.

Schizophr Bull. 2007 Jan;33(1):21-32. Review.

20.

Developing therapeutics for schizophrenia and other psychotic disorders.

Marek G, Merchant K.

NeuroRx. 2005 Oct;2(4):579-89. Review.

Items per page

Supplemental Content

Support Center